|
Recent Developments |
|
28-FEB-13
Cipla, leading drug maker, announced that the board of directors of the company, decided to acquire 100% of the ordinary shares of Medpro at a price of ZAR 10 a share, and to settle all outstanding share options therein.
06-FEB-13
Cipla, leading drug maker, announced today that YK Hamied, CMD, is going to retire with effect on Mar. 31,2013. MK Hamied will now continue as single MD. MK Hamied has been there for around 10 years and YK ... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 31-Dec-2012(9) | 31-Mar-2012 (12) | 31-Mar-2011 (12) | | Net sales | 60939.50 | 68076.80 | 61351.60 | | Other Income | 1706.80 | 1483.00 | 1045.80 | | Total Income | 62646.30 | 69559.80 | 62397.40 | | Cost of goods sold | 45108.30 | 53956.40 | 50293.20 | | OPBDIT | 17538.00 | 15603.40 | 12104.20 | | PAT | 12395.50 | 11239.60 | 9603.90 | | Gross Block | - | - | - | | Equity capital | 1605.80 | 1605.80 | 1605.80 | | EPS (Rs.) | - | 14.00 | 11.96 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 19.58 - 25.64 | 23.92 - 31.84 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 28.0 | 22.4 | 19.4 | | Net margin (% of OI) | 19.8 | 16.2 | 15.4 |
|
|
Detailed Financials
|
|
|
|
|
Snapshot
